Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP321099.RAMgvIPqPFLCnYyfhtfv8TC0Es2kJg0alp4V2CvtV_cBA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP321099.RAMgvIPqPFLCnYyfhtfv8TC0Es2kJg0alp4V2CvtV_cBA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP321099.RAMgvIPqPFLCnYyfhtfv8TC0Es2kJg0alp4V2CvtV_cBA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP321099.RAMgvIPqPFLCnYyfhtfv8TC0Es2kJg0alp4V2CvtV_cBA130_provenance.
- NP321099.RAMgvIPqPFLCnYyfhtfv8TC0Es2kJg0alp4V2CvtV_cBA130_assertion description "[We used stored plasma samples from 409 patients in the National Institute of Neurological Diseases and Stroke (NINDS) tissue plasminogen activator (t-PA) Stroke Trial to examine the relationship between an apolipoprotein (Apo) E2 or an Apo E4 phenotype and a favorable outcome 3 months after stroke, the risk of intracerebral hemorrhage, and the response to intravenous t-PA therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP321099.RAMgvIPqPFLCnYyfhtfv8TC0Es2kJg0alp4V2CvtV_cBA130_provenance.
- NP321099.RAMgvIPqPFLCnYyfhtfv8TC0Es2kJg0alp4V2CvtV_cBA130_assertion evidence source_evidence_literature NP321099.RAMgvIPqPFLCnYyfhtfv8TC0Es2kJg0alp4V2CvtV_cBA130_provenance.
- NP321099.RAMgvIPqPFLCnYyfhtfv8TC0Es2kJg0alp4V2CvtV_cBA130_assertion SIO_000772 11409425 NP321099.RAMgvIPqPFLCnYyfhtfv8TC0Es2kJg0alp4V2CvtV_cBA130_provenance.
- NP321099.RAMgvIPqPFLCnYyfhtfv8TC0Es2kJg0alp4V2CvtV_cBA130_assertion wasDerivedFrom befree-2016 NP321099.RAMgvIPqPFLCnYyfhtfv8TC0Es2kJg0alp4V2CvtV_cBA130_provenance.
- NP321099.RAMgvIPqPFLCnYyfhtfv8TC0Es2kJg0alp4V2CvtV_cBA130_assertion wasGeneratedBy ECO_0000203 NP321099.RAMgvIPqPFLCnYyfhtfv8TC0Es2kJg0alp4V2CvtV_cBA130_provenance.
- befree-2016 importedOn "2016-02-19" NP321099.RAMgvIPqPFLCnYyfhtfv8TC0Es2kJg0alp4V2CvtV_cBA130_provenance.